Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients

Fatemeh TajikRostami, Majid Rezaei Tavirani, Elnaz Ataei, Mostafa Rezaei-Tavirani, Hamid Mohaghegh-Shalmani, Mohsen Norouzinia · 2025

Read Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients by Fatemeh TajikRostami, Majid Rezaei Tavirani, Elnaz Ataei, Mostafa Rezaei-Tavirani, Hamid Mohaghegh-Shalmani, Mohsen Norouzinia (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13081421.txt.

Description

Fatemeh TajikRostami and co-authors present a 2025 study on why rectal cancer patients respond differently to pre-surgery treatment. Chemotherapy and radiation before surgery, called neoadjuvant therapy, fully clear the tumor in some patients and not in others. The team compared gene activity between the two response groups.

Public gene data yielded 606 genes that differed between complete and incomplete responders. Network analysis pointed to five key genes at the center of the response pattern. Groups of biological terms tied to growth control also stood out. The authors argue that genetic variation between patients helps explain the split outcomes. Treatment gains, they suggest, will need a precision medicine approach that reads each tumor's profile.

Catalog record

CREATORFatemeh TajikRostami, Majid Rezaei Tavirani, Elnaz Ataei, Mostafa Rezaei-Tavirani, Hamid Mohaghegh-Shalmani, Mohsen Norouzinia
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE14 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13081421

Browse the full library · About the Tower of Babel